Fresenius Medical Care AG EBIT

The latest EBIT for FMS is $1.7B as of June 2026. That compares with $1.6B in the prior-year period — up 9.7% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Fresenius Medical Care AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, FMS's EBIT moved from $1.6B to $1.7B — a 9.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fresenius Medical Care AG's operating scale or balance-sheet position.

Against Healthcare companies, FMS currently prints $1.7B for EBIT, while the sector average sits near $23B. That is roughly 92.6% below the sector mean. Large gaps often invite a closer look at Fresenius Medical Care AG's growth, margins, and balance sheet.

A EBIT figure of $1.7B for FMS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.

After noting FMS's EBIT ($1.7B), review year-over-year change from $1.6B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.